five

S.aureus TMK in complex with potent inhibitor compound 19, 2-(3-CHLOROPHENOXY)-3-FLUORO-4-{[(3S)-3-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)PIPERIDIN-1-YL]METHYL}BENZOIC ACID

收藏
Protein Data Bank Japan2024-02-28 更新2026-03-21 收录
下载链接:
https://pdbj.org/mine/summary/4qga
下载链接
链接失效反馈
官方服务:
资源简介:
S.aureus TMK in complex with potent inhibitor compound 19, 2-(3-CHLOROPHENOXY)-3-FLUORO-4-{[(3S)-3-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)PIPERIDIN-1-YL]METHYL}BENZOIC ACID Descriptor: 2-(3-chlorophenoxy)-3-fluoro-4-{[(3S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl]methyl}benzoic acid, Thymidylate kinase Authors: Olivier, N.B. Deposit date: 2014-05-22 Release date: 2014-06-11 Last modified: 2024-02-28 Method: X-RAY DIFFRACTION (1.94 Å) Cite: Antibacterial inhibitors of gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding region. J.Med.Chem., 57, 2014

与强效抑制剂化合物19——2-(3-氯苯氧基)-3-氟-4-{[(3S)-3-(5-甲基-2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)哌啶-1-基]甲基}苯甲酸——结合的金黄色葡萄球菌(Staphylococcus aureus)胸苷酸激酶(Thymidylate kinase, TMK)。描述项:2-(3-氯苯氧基)-3-氟-4-{[(3S)-3-(5-甲基-2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)哌啶-1-基]甲基}苯甲酸,胸苷酸激酶(Thymidylate kinase)。作者:Olivier, N.B.。提交日期:2014-05-22。发布日期:2014-06-11。最后修改日期:2024-02-28。实验方法:X射线衍射(1.94 Å)。引用文献:《革兰氏阳性菌胸苷酸激酶的抗菌抑制剂:新型疏水结合区域的构效关系与手性偏好》,《药物化学杂志》(J.Med.Chem.),第57卷,2014年
创建时间:
2014-05-22
二维码
社区交流群
二维码
科研交流群
商业服务